LigaChem Biosciences Inc. (141080.KQ)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Yong Zu Kim Ph.D. | CEO, President & Director | -- | -- | 1956 |
| Mr. Sejin Park | CFO, COO, Vice President & Director | -- | -- | 1962 |
| Dr. Chul-Woong Chung Ph.D. | Chief Technology Officer | -- | -- | -- |
| Mr. Jeiwook Chae | Chief Business Development Officer | -- | -- | -- |
| Dr. Young-Lag Cho Ph.D. | Chief Development Officer & Head Researcher & Development | -- | -- | -- |
| Dr. Rodrigo Ruiz Soto M.D. | Chief Medical Officer | -- | -- | -- |
LigaChem Biosciences Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.
Corporate Governance
Upcoming Events
May 14, 2025 at 10:59 AM UTC - May 19, 2025 at 12:00 PM UTC
LigaChem Biosciences Inc. Earnings Date
Recent Events
Recent Events Information Not Available